Previous 10 | Next 10 |
Completed enrollment in Phase 2b sickle cell disease and beta-thalassemia trials with tovinontrine (IMR-687); expect to report both interim datasets in first week of April 2022 Changed primary endpoint of Ardent Phase 2b trial in sickle cell disease to reductions in annualized r...
BOSTON, March 08, 2022 (GLOBE NEWSWIRE) -- Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare hemoglobin disorders and other serious diseases, today announced that the com...
Gainers: HOOKIPA Pharma HOOK +18%. Nuvectis Pharma (NASDAQ:NVCT) +16%. Ocugen OCGN +14%. Privia Health (NASDAQ:PRVA) +12%. IMARA (NASDAQ:IMRA) +11%. Losers: Allarity Therapeutics (NASDAQ:ALLR) -29%. Homology Medicines FIXX -27%. Karyopharm The...
Meritor (NYSE:MTOR) +43% Cummins acquires Meritor with eyes on electric power applications. Digital World Acquisition (NASDAQ:DWAC) +17% Trump's TRUTH Social platform hits Apple's App Store. Ocugen (NASDAQ:OCGN) +16% after FDA lifted hold on study for COVID-19 va...
There are many ways to find the best penny stocks to buy , including hunting for chart set-ups and looking for unusual trading activity. Others focus their strategy around finding top stocks under $1 or even below $0.50 that might be considered a good long shot investment opportunit...
BOSTON, Feb. 10, 2022 (GLOBE NEWSWIRE) -- Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare hemoglobin disorders and other serious diseases, today announced that Rahul Ba...
In this article, we take a closer look at 5 penny stocks gaining ground after releasing big news today. Thanks to even more stock market uncertainty, retail traders have turned attention to daily trends, and rightfully so. The last week has seen markets pop and drop significant percentages ...
Expanding patient base and potential of Imara’s small molecule oral inhibitor of phosphodiesterase-9 (PDE9) alongside hemoglobin disorders Phase 2 trial aims to select HFpEF patients with enriched PDE9 expression for targeted approach to a heterogeneous disease ...
BOSTON, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat subjects suffering from rare inherited genetic disorders of hemoglobin and other serious diseases, today an...
Oral presentation provides first look at new program, IMR-261, a novel, oral, clinic-ready nuclear factor erythroid 2-related factor 2 (Nrf2) activator SCD Townes mouse model demonstrates IMR-261 activation of Nrf2 increases HbF and F-cells, reduces VOCs and reduces markers of a...
News, Short Squeeze, Breakout and More Instantly...
IMARA Inc. Company Name:
IMRA Stock Symbol:
NASDAQ Market:
-- Combined Company to Trade on Nasdaq Under Ticker “ELVN” -- -- Imara Announces 1-for-4 Reverse Stock Split of Common Stock -- BROOKLINE, Mass., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Imara Inc. (Nasdaq: IMRA) today announced the results of the special meeting of its stock...
There are plenty of ways to find the best penny stocks to buy. The first step, however, is knowing your idea of “best.” Everyone has a different style of trading and investing they subscribe to. Some look for entry opportunities to buy penny stocks and hold them long-term. O...
Insiders Play The Stock Market Game With Penny Stocks Want to find penny stocks to buy? How about trying the “Follow The Money” trend? It’s becoming more popular lately, especially in light of the recent stock market game being played. One day markets are up; th...